Last Updated on August 6, 2023 by The Health Master
Granules India announced that Granules Pharmaceuticals, located in Chantilly, Virginia, has successfully completed the United States Food and Drug Administration (USFDA) Post-Marketing Adverse Drug Experience (PADE) Inspection for all its entities in the US, including Granules India.
The inspection was conducted at Granules Pharmaceuticals from July 31, 2023, to August 03, 2023.
This inspection covered the Granules’ PADE surveillance, receipts, evaluations, processing, and reporting system for the marketed drug products worldwide.
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon: